Over $30 Billion Needed For COVID-19 Tests, Treatments, Vaccines: WHO.

Over $30 Billion Needed For COVID-19 Tests, Treatments, Vaccines: WHO

Coronavirus: So far, $3.4 billion of that had been pledged, WHO said (File)

Geneva:

The World Health Organization said Friday that a global initiative to speed up the development and production of COVID-19 tests, vaccines and treatments will require more than $30 billion over the next year.

Providing details of the so-called ACT accelerator, launched in April and aimed at pooling international resources to conquer the pandemic, WHO said "the costed plans presented today call for $31.3 billion in funding."

So far, $3.4 billion of that had been pledged, it said, pointing out that an additional $27.9 billion was needed over the next 12 months, including nearly $14 billion to cover immediate needs.

The announcement came ahead of a major pledging event in Brussels in support of the ACT accelerator, set to take place on Saturday.

"This is an investment worth making," Ngozi Okonjo-Iweala, a special envoy for the ACT accelerator, told a virtual briefing.

"If we don't rally now, the human costs and the economic pain will deepen," she said.

"Though these numbers sound big, they are not when we think of the alternative. If we spend billions now, we will be able to avoid spending trillions later."

"The time to act is now, and the way to act is together."

Okonjo-Iweala's comments came as the world counts nearly 490,000 deaths from COVID-19 and over 9.6 million cases since the new coronavirus emerged in China late last year, according to an AFP tally from official sources.

The funds requested should make it possible to deliver 500 million tests and 245 million courses of treatment to low and middle-income countries by mid-2021.

They also aim to deliver two billion vaccine doses by the end of next year, of which half will go to low and middle-income nations.

"It's clear that to bring COVID-19 under control, and to save lives, we need effective vaccines, diagnostics and therapeutics, in unprecedented quantities and at unprecedented speed," WHO chief Tedros Adhanom Ghebreyesus told the briefing.

Separate teams are racing to roll out reliable tests, find safe and effective vaccines and treatments for the novel coronavirus, and prepare for large-scale manufacturing.

Tedros meanwhile stressed that a core principle of the initiative is to ensure equal access for all.

"Vaccines, diagnostics and therapeutics are vital tools," he said.

"But to be truly effective they must be administered with another essential ingredient, which is solidarity."

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Comments

Related news

Trump Still Sees Hydroxychloroquine As Promising Virus Cure: White House.

President Donald Trump continues to see a malaria drug, hydroxychloroquine, as a promising drug to be used to prevent infection with the coronavirus, the White House said on Thursday, though the US...

Clothes, bedsheets taken away from Ghislaine Maxwell due to suicide concerns: official.

The steps to ensure Maxwell’s safety while she’s locked up at a federal jail in New York City extend far beyond the measures federal officials took when they first arrested her in New Hampshire last week.

1 57

USMCA won’t limit Canadian retaliation against U.S. tariffs: negotiator

Steve Verheul say that under the terms of the May 2019 agreement on tariffs, Canada would be able to impose retaliatory levies against American aluminum.

Twin girls, conjoined at the skull, successfully separated in 18-hour operation in Italy.

Conjoined twins of this kind only happen in around every two million births.

Nepal Cable Operators Block Indian News Channels: Report.

Nepal's Cable television providers have said that signals for Indian news channels, except Doordarshan, have been switched off in the country. There is, however, no official order issued in this...

By continuing to browse World News (UAZMI), you acknowledge that you have read the Terms of Use and agree to the use of cookies